Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis

Acta Dermato-Venereologica

Volumn 85, Issue 5, 2005, Pages 420-423

  Sánchez Regaña, Manuel ^a   Martín Ezquerra, Gemma ^a   Umbert Millet, Pablo ^a  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

Author keywords

Parathyroid hormone; Parathyroid hormone related peptide; Psoriasis; Psoriatic activity

Indexed keywords

MOMETASONE FUROATE; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PREGNADIENEDIOLS; PSORIASIS;

EID: 25144494814     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.1080/00015550510033705     Document Type: Article

References (25)

1. Ferrándiz C, Bordas X, García-Patos V, Puig S, Pujol R, Smandia A. Prevalence of psoriasis in Spain (Epiderma Project: phase I). J Eur Acad Derm Venereol 2001; 15: 20-23.
2. Risum G. Psoriasis exacerbated by hypoparathyroidism with hypocalcemia. Br J Dermatol 1973; 89: 309-312.
3. Kawamura A, Tan Kinoshita M, Suzuki H. Generalized pustular psoriasis with hypoparathyroidism. Eur J Dermatol 1999; 9: 574-576.
4. Sánchez Regaña M, Umbert P. Psoriasis in association with prolactinoma: three cases. Br J Dermatol 2000; 143: 864-867.
5. Sánchez Regaña M, Ojeda R, Umbert P. Elevated serum parathyroid hormone levels in a patient with annular pustular psoriasis. J Eur Acad Dermatol Venereol (In press).
6. Milstone LM, Ellison AF, Insogna KL. Serum parathyroid hormone level is elevated in some patients with disorders of keratinisation. Arch Dermatol 1992; 128: 926-930.
7. Milstone LM, Bale SJ, Insogna KL. Secondary hyperparathyroidism in patients with ichthyosis is not caused by vitamin D deficiency or ingestion of retinoids. Arch Dermatol 1993; 129: 648.
8. Rico H, Robledo A, Crabranes JA, Lopez-Bran E, Hernandez ER. Behavior of calciotropic hormones in psoriasis. Miner Electrolyte Metab 1991; 17: 12-15.
9. Wishart JM. Calcitriol (1alpha, 25-dihydroxyvitamin D3) ointment in psoriasis, a safety tolerance and efficacy multicentre study. Dermatology 1994; 188: 135-139.
10. Gumowski-Sunek D, Rizzoli R, Saurat JH. Effects of topical calcipotriol on calcium metabolism in psoriatic patients: comparison to oral calcitriol. Dermatologica 1991; 183: 275-279.
11. Guilhou JJ, Colette C, Monpoint S, Lancrenon E, Guillot B, Monnier L. Vitamin D metabolism in psoriasis before and after phototherapy. Acta Derm Venereol 1990; 70: 351-354.
12. Juhlin L, Hagforsen E, Juhlin C. Parathyroid hormone related protein is localized in the granular layer of normal skin and in the dermal infiltrates of mycosis fungoides but is absent in psoriatic lesions. Acta Derm Venereol 1992; 72: 81-83.
13. Sharpe GR, Dillon JP, Durham B, Gallagher JA, Fraser WD. Human keratinocytes express transcripts for three isoforms of parathyroid hormone-related protein (PTHrP), but not for the parathyroid hormone/PTHrP receptor: effects of 1,25 (OH)2 vitamin D3. Br J Dermatol 1998; 138: 944-951.
14. Holick MF, Chimeh FN, Ray S. Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomised self-controlled trial and an open trial. Br J Dermatol 2003; 149: 370-376.
15. Lang PG. The clinical spectrum of parathyroid disease. J Am Acad Dermatol 1981; 5: 733-744.
16. Cohen FE, Strewler GJ, Bradley MS, Carlquist M, Nilsson M, Ericsson M, et al. Analogues of parathyroid hormone modified at positions 3 and 6. J Biol Chem 1991; 266: 1997-2004.
17. Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med 2000; 342: 177-185.
18. Owen CM, Blewitt RW, Harrison PV, Yates VM. Two cases of primary hyperparathyroidism associated with primary cutaneous lymphoma. Br J Dermatol 2000; 142: 120-123.
19. Maerens-Tchokokam B, Bailly N, Collet E, Dalac S, Rat P, Lambert D. Mélanome et hyperparathyroïdie primaire. Ann Dermatol Venereol 1993; 120: 215-217.
20. London RD, Lebwohl M. Acquired ichthyosis and hyperparathyroidism. J Am Acad Dermatol 1989; 21: 801-802.
21. Sánchez Regaña M, Catasús M, Creus L, Umbert P. Serum neopterin as an objective marker of psoriatic disease activity. Acta Derm Venereol 2000; 80: 185-187.
22. DiGiovanna JJ, Sollitto RB, Abangan DL, Steinberg SM, Reynolds JC. Osteoporosis is a toxic effect of long-term etretinate therapy. Arch Dermatol 1995; 131: 1263-1267.
23. Nymann P, Kollerup G, Jemec GB, Grossmann E. Decrease bone mineral density in patients with pustulosis palmaris et plantaris. Dermatology 1996; 192: 307-311.
24. Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker JN. Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 2001; 26: 446-448.
25. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002; 77: 453-468.